carmustine has been researched along with Paranasal Sinus Neoplasms in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Paranasal Sinus Neoplasms: Tumors or cancer of the PARANASAL SINUSES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Esthesioneuroblastoma (olfactory neuroblastoma) is a rare neuroendocrine tumor that arises in the upper nasal cavity from the olfactory epithelium." | 2.40 | Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience. ( Buckner, JC; Lewis, JE; McElroy, EA, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabezas-Camarero, S | 1 |
| de la Orden García, V | 1 |
| García-Barberán, V | 1 |
| Mediero-Valeros, B | 1 |
| Subhi-Issa, AI | 1 |
| Llovet García, P | 1 |
| Bando-Polaino, I | 1 |
| Merino Menéndez, S | 1 |
| Pérez-Segura, P | 1 |
| Díaz-Rubio, E | 1 |
| McElroy, EA | 1 |
| Buckner, JC | 1 |
| Lewis, JE | 1 |
| Krackhardt, A | 1 |
| Schwartz, S | 1 |
| Korfel, A | 1 |
| Thiel, E | 1 |
1 review available for carmustine and Paranasal Sinus Neoplasms
| Article | Year |
|---|---|
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; | 1998 |
2 other studies available for carmustine and Paranasal Sinus Neoplasms
| Article | Year |
|---|---|
Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Immunological; Antineoplastic Combined Che | 2019 |
Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
Topics: Acute Kidney Injury; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pro | 1999 |